Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding potentially dilutive ordinary shares were excluded from the computation of diluted net loss per share attributable to ordinary stockholders for the periods presented, as their effect would have been antidilutive:
Three Months Ended March 31,
2022 2021
(in thousands)
Stock options 8,361  9,611 
Restricted stock units 174  351 
Convertible preferred stock warrants and option —  2,347 
Other awards including contingently issuable shares —  78 
Total anti-dilutive shares 8,535  12,387